Inotiv logo

InotivNASDAQ: NOTV

Profile

Sector:

Healthcare

Country:

United States

IPO:

25 November 1997

Next earnings report:

11 December 2024

Last dividends:

N/A

Next dividends:

N/A
$92.83 M
-93%vs. 3y high
43%vs. sector
-vs. 3y high
-vs. sector
-96%vs. 3y high
26%vs. sector
-98%vs. 3y high
6%vs. sector

Price

after hours | Sat, 23 Nov 2024 00:54:23 GMT
$3.57$0.00(0.00%)

Dividend

No data over the past 3 years
$105.79 M$116.94 M
$105.79 M-$26.09 M

Analysts recommendations

Institutional Ownership

NOTV Latest News

Inotiv, Inc. Amends Its Credit Agreement and Secures Additional Liquidity
globenewswire.com16 September 2024 Sentiment: POSITIVE

WEST LAFAYETTE, Ind., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, has amended certain terms of its Credit Agreement. In addition, Inotiv has closed the sale of $22.6 million aggregate principal amount of 15% Senior Secured Second Lien PIK Notes due February 2027 (the “Second Lien Notes”), and warrants to purchase common shares, to certain investors in a private offering.

Inotiv, Inc. Provides Business Updates
globenewswire.com10 June 2024 Sentiment: POSITIVE

WEST LAFAYETTE, Ind., June 10, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today provided the following business updates:

Inotiv Reaches Agreement to Resolve Previously-Announced Investigation into Shuttered Cumberland Facility
globenewswire.com03 June 2024 Sentiment: POSITIVE

Company reaffirms commitment to maintaining appropriate standards of animal welfare Company reaffirms commitment to maintaining appropriate standards of animal welfare

Inotiv, Inc. to Participate in Upcoming Craig Hallum and Jefferies Investor Conferences
globenewswire.com23 May 2024 Sentiment: POSITIVE

WEST LAFAYETTE, Ind., May 23, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that Robert Leasure Jr., President and Chief Executive Officer, and Beth Taylor, Chief Financial Officer, will participate in the upcoming 21st Annual Craig Hallum Institutional Investor Conference and Jefferies Global Healthcare Conference.

Why Is Inotiv (NOTV) Stock Down 35% Today?
InvestorPlace14 May 2024 Sentiment: NEGATIVE

Inotiv stock is experiencing a decline on Tuesday following the release of preliminary results for Q1 2024 by the drug discovery and development services company. The company has reported that its revenue for the six months ending on March 31, 2024 is expected to be $254.5 million.

Inotiv (NOTV) Is a Great Choice for 'Trend' Investors, Here's Why
Zacks Investment Research03 April 2024 Sentiment: POSITIVE

If you are looking for stocks that are well positioned to maintain their recent uptrend, Inotiv (NOTV) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Why Fast-paced Mover Inotiv (NOTV) Is a Great Choice for Value Investors
Zacks Investment Research02 April 2024 Sentiment: POSITIVE

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Inotiv (NOTV) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

Is Inotiv (NOTV) a Great Value Stock Right Now?
Zacks Investment Research25 March 2024 Sentiment: POSITIVE

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Here's Why Momentum in Inotiv, Inc. (NOTV) Should Keep going
Zacks Investment Research18 March 2024 Sentiment: POSITIVE

Inotiv, Inc. (NOTV) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Rocket Stocks: 3 Picks That Could Skyrocket Your Portfolio by 2025
InvestorPlace12 March 2024 Sentiment: POSITIVE

In the stock market, identifying the next big opportunity is like observing a celestial phenomenon. Today, through the cosmos of investment, three shining stars are identified for their potential for astronomical valuation possibilities.

  • 1(current)
  • 2

What type of business is Inotiv?

Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company offers research and discovery services, including computational toxicology, disease pharmacology, DMPK, safety pharmacology, discovery bioanalysis, exploratory, surgical models and medical device, and cell and molecular biology; non-clinical safety assessment includes general and genetic toxicology, regulated bioanalysis, carcinogenicity studies, and development and reproductive toxicology; pathology services, such as histology, digital, clinical, and medical device pathology; bioanalysis includes nonregulated discovery bioanalysis, biotherapeutics, and regulated preclinical and clinical bioanalysis; proteomics; and consulting services, as well as model and research services. The company operates in the United States, the Netherlands, and internationally. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana.

What sector is Inotiv in?

Inotiv is in the Healthcare sector

What industry is Inotiv in?

Inotiv is in the Diagnostics & Research industry

What country is Inotiv from?

Inotiv is headquartered in United States

When did Inotiv go public?

Inotiv initial public offering (IPO) was on 25 November 1997

What is Inotiv website?

https://www.inotivco.com

Is Inotiv in the S&P 500?

No, Inotiv is not included in the S&P 500 index

Is Inotiv in the NASDAQ 100?

No, Inotiv is not included in the NASDAQ 100 index

Is Inotiv in the Dow Jones?

No, Inotiv is not included in the Dow Jones index

When was Inotiv the previous earnings report?

No data

When does Inotiv earnings report?

The next expected earnings date for Inotiv is 11 December 2024